PEP

· Rion Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEP, covering 2024-06-17 to 2024-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA) [Phase 1]